300412.SHE Zhejiang Canaan Technology Co Ltd
- Market cap
- CNY 1.96B
- P/E
- 131.0x
- P/B
- 1.87x
- ROE
- -0.9%
- Dividend yield
- 2.17%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300412.SHE undervalued?
Graham numberThe Graham number of Zhejiang Canaan Technology Co Ltd cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Zhejiang Canaan Technology Co Ltd fundamental analysis
No fundamental analysis for Zhejiang Canaan Technology Co Ltd yet.
Zhejiang Canaan Technology Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Zhejiang Canaan Technology Co Ltd
Zhejiang Canaan Technology Limited engages in the research and development, production, and sale of pharmaceutical equipment in China and internationally. The company offers preprocessing modules, hybrid modules, packaging, attachment, granulation, material transport, cleaning, continuous manufacturing, container, freeze drying system, molding module, and fluid module products, as well as filter washer dryer. It also provides EPCMV turnkey, solid dosage, API system, pharmace…
Full company profileZhejiang Canaan Technology Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Zhejiang Canaan Technology Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 302M | 445M | 579M | 703M | 1.01B | 1.06B | 1.10B | 1.05B | 1.38B | 1.23B | 991M |
| Gross Profit | 150M | 186M | 218M | 262M | 287M | 303M | 253M | 256M | 327M | 303M | 238M |
| Operating Income | 60.1M | 56.5M | 52.5M | 76.1M | 89.7M | 101M | -87.5M | -25.5M | 36.1M | 50.2M | -6.66M |
| EBITDA | 79.7M | 69.9M | 72.3M | 101M | 116M | 132M | -56.1M | 17.8M | 94.7M | 101M | -879K |
| Net Income | 57.0M | 44.0M | 33.6M | 51.3M | 67.9M | 73.7M | -75.2M | -23.4M | 36.3M | 29.6M | -8.82M |
| EPS | 0.14 | 0.10 | 0.08 | 0.12 | 0.15 | 0.16 | -0.15 | -0.05 | 0.07 | 0.06 | -0.02 |
| Balance Sheet | |||||||||||
| Total Assets | 1.01B | 1.21B | 1.36B | 1.52B | 1.76B | 2.31B | 2.50B | 2.60B | 2.48B | 2.53B | 2.66B |
| Total Liabilities | 245M | 391M | 524M | 678M | 871M | 1.13B | 1.42B | 1.54B | 1.40B | 1.44B | 1.60B |
| Shareholders' Equity | 740M | 776M | 785M | 796M | 838M | 1.13B | 1.04B | 1.02B | 1.05B | 1.05B | 1.02B |
| Cash & Short-term Investments | 385M | 258M | 277M | 299M | 324M | 489M | 390M | 295M | 363M | 329M | 484M |
| Total Debt | 2.00M | 23.0M | 53.0M | 79.2M | 182M | 236M | 268M | 484M | 424M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 24.7M | -26.3M | -21.6M | 41.5M | 55.5M | 75.0M | 68.6M | -53.6M | 119M | 185M | - |
| Capital Expenditure | 19.1M | 81.0M | 52.2M | 17.3M | 81.5M | 155M | 166M | 165M | 54.4M | 39.4M | 14.1M |
| Free Cash Flow | 5.58M | -107M | -73.8M | 24.2M | -26.0M | -79.8M | -97.1M | -228M | 65.1M | 145M | 86.7M |
| Ratios | |||||||||||
| ROE | 7.7% | 5.7% | 4.3% | 6.4% | 8.1% | 6.5% | -7.2% | -2.3% | 3.4% | 2.8% | -0.9% |
| ROA | 5.7% | 3.6% | 2.5% | 3.4% | 3.9% | 3.2% | -3.0% | -0.9% | 1.5% | 1.2% | -0.3% |
| Net Profit Margin | 18.9% | 9.9% | 5.8% | 7.3% | 6.7% | 7.0% | -6.8% | -2.2% | 2.6% | 2.4% | -0.9% |
| Debt to Equity | 0.00x | 0.03x | 0.07x | 0.10x | 0.22x | 0.21x | 0.26x | 0.48x | 0.40x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Zhejiang Canaan Technology Co Ltd dividends
- Dividend yield
- 2.17%
- Forward dividend
- 0.06 CNY
- Payout ratio
- 143.1%
- Ex-dividend date
- Jun 1, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 42.4M | 0.09 | 143.1% |
| 2024 | CNY 15.4M | 0.03 | 42.5% |
| 2023 | CNY 11.0M | 0.02 | - |
| 2022 | CNY 17.6M | 0.04 | - |
| 2021 | CNY 41.2M | 0.09 | 55.8% |
| 2020 | CNY 40.8M | 0.09 | 60.1% |
| 2019 | CNY 28.1M | 0.06 | 54.7% |
| 2018 | CNY 30.7M | 0.07 | 91.3% |
| 2017 | CNY 32.5M | 0.07 | 73.8% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.7:1 on Jun 9, 2022.
Who owns Zhejiang Canaan Technology Co Ltd
- Insiders 34.62%
- Institutions 1.38%
- Public & others 64.00%
- Shares outstanding 498M
- Free float 702M
Zhejiang Canaan Technology Co Ltd company profile
- Company name
- Zhejiang Canaan Technology Co Ltd
- Ticker
- 300412.SHE
- ISIN
- CNE100001Y75
- Exchange
- Shenzhen Stock Exchange
- Sector
- Industrials
- Industry
- Health Care Equipment & Supplies
- Employees
- 1,582
- Fiscal year end
- December
- Address
- No. 1188, Jiangnan Avenue, Wenzhou, China, 325102
- Phone
- 86 577 6737 8885
- Website
- china-jianan.com
About Zhejiang Canaan Technology Co Ltd
Zhejiang Canaan Technology Limited engages in the research and development, production, and sale of pharmaceutical equipment in China and internationally. The company offers preprocessing modules, hybrid modules, packaging, attachment, granulation, material transport, cleaning, continuous manufacturing, container, freeze drying system, molding module, and fluid module products, as well as filter washer dryer. It also provides EPCMV turnkey, solid dosage, API system, pharmaceutical water, smart packaging, intelligent warehousing and automated logistics, pharmaceutical research and development integrated services, and pharmaceutical digital solutions. It primarily serves pharmaceutical industry. The company was founded in 2000 and is based in Wenzhou, China.
Zhejiang Canaan Technology Co Ltd management
3- Mr. Zheng FangGM & Chairman · born 1982
- Mr. Haizhi XuCFO, Accounting Supervisor & Non-Independent Director · born 1975
- Mr. Hu ChaoDeputy GM, Secretary of the Board & Non-Independent Director · born 1982